Original language | English |
---|---|
Pages (from-to) | 233-234 |
Number of pages | 2 |
Journal | The Lancet |
Volume | 399 |
Issue number | 10321 |
Early online date | 16 Dec 2021 |
DOIs | |
Publication status | Published - Jan 2022 |
Bibliographical note
Funding Information:Members of the COVIDSurg Collaborative are listed in the appendix . The authors declare no competing interests. The work presented in this Correspondence was funded by a National Institute for Health Research (NIHR) Global Health Research Unit Grant (NIHR 16.136.79), Association of Coloproctology of Great Britain and Ireland, Bowel and Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, Medtronic, Sarcoma UK, The Urology Foundation, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research. The funders had no role in study design, data collection, analysis and interpretation, or writing of this Correspondence. The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR, or the UK Department of Health and Social Care.
Keywords
- COVID-19/epidemiology
- Communicable Disease Control/standards
- Elective Surgical Procedures/standards
- England/epidemiology
- Forecasting
- Health Services Accessibility/organization & administration
- Hospitalization/statistics & numerical data
- Humans
- State Medicine/organization & administration
ASJC Scopus subject areas
- General Medicine